Tenet Healthcare diskutieren
Tenet Healthcare
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Aktie / Anbieter & Dienstleistungen / Mid Cap /
196,00 €
0,00 %
Tenet Healthcare (NYSE:THC) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target lowered by analysts at TD Cowen from $233.00 to $230.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) was given a new $288.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Jefferies Financial Group Inc. from $250.00 to $265.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Truist Financial Corporation from $240.00 to $270.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Leerink Partners from $255.00 to $264.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) had its price target raised by Mizuho from $235.00 to $265.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Dollar General Corp. diskutieren